Apyx medical corporation to release fourth quarter and fiscal year 2021 financial results on march 17, 2022

Clearwater, fla.--(business wire)--apyx medical corporation (nasdaq:apyx) (the “company”), a maker of medical devices and supplies and the developer of helium plasma technology, marketed and sold as renuvion® in the cosmetic surgery market and j-plasma® in the hospital surgical market, today announced that financial results for the fourth quarter and fiscal year 2021 will be released before the market opens on thursday, march 17th. management will host a conference call at 8:00 a.m. eastern tim
APYX Ratings Summary
APYX Quant Ranking